The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Wound dressing involves use of dressing products combined with drug formulations to provide enhanced healing properties. GlobalData uses proprietary data and analytics to provide a comprehensive report on the wound dressings market in Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the wound dressings market in Japan was 3M followed by B. Braun Melsungen, Coloplast, ConvaTec Group, Molnlycke Health Care, Smith & Nephew and Urgo.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Wound dressings are majorly used for the treatment of chronic wounds where they provide a moist and active dressings environment for optimum healing. Advanced wound dressings are also used for treating acute wounds such as surgical procedures, burns, and traumatic wounds. This category includes semi-permeable films, foams, hydrofibers, hydrocolloids, hydrogels, alginates, collagens.
The wound dressings market in Japan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size wound dressings in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
